Milodistim
Alternative Names: GM-CSF/IL-3; PIXY 321; Pixykine; Plasmid Immunex yeast 321Latest Information Update: 24 Oct 2021
At a glance
- Originator Amgen
- Class Colony-stimulating factors
- Mechanism of Action Granulocyte macrophage colony stimulating factor agonists; Interleukin 3 stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Chemotherapy-induced damage; Neutropenia; Thrombocytopenia
Most Recent Events
- 23 Nov 1998 A clinical study has been added to the Haematological disorders therapeutic trials and pharmacokinetics sections
- 29 Nov 1996 A study has been added to the Haematological disorders therapeutic trials and adverse effects sections
- 11 Jul 1996 A clinical study has been added to the Cancer therapeutic trials and adverse events sections